Info

home SymbolABVC

Exchange: NASDAQ·Updated 07:30 PM EDT

ABVC ABVC BioPharma Inc

$0.92

$0.0079

(0.86%)

Today

Closed $0.91

$0.01

(1.10%)

After Hours

Mkt Cap$24.5M

Vol26,891.00

About ABVC

ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.